Shelvin Kumar Vadi

About

Shelvin Kumar Vadi is a leading researcher in molecular imaging and interventional oncology, with a focus on advancing PET/CT-guided biopsy techniques. His major contributions center on the development and validation of robotic-assisted biopsy methods for diagnosing prostate cancer and other metabolically active lesions. Vadi pioneered the use of 68Ga-PSMA PET/CT-guided robotic-assisted transgluteal prostatic biopsy, demonstrating its superior safety and diagnostic yield over traditional methods—a study that has garnered 38 citations. His work on 18F-FDG PET/CT-guided percutaneous biopsies using automated robotic arms (21 citations) and Ga-68 avid lesion biopsies (17 citations) has established new standards for precision in targeting difficult-to-reach abdominal and pelvic lesions. Collectively, his highly cited papers have shaped clinical practice by reducing procedural risks and improving cancer detection rates. Vadi’s innovative integration of robotics with advanced PET tracers represents a significant leap forward in minimally invasive diagnostics, making him a key figure in the evolution of image-guided interventions.

Research Focus

Key Achievements

Top Papers

1. 1
   Safety and Diagnostic Yield of⁶⁸Ga Prostate-specific Membrane Antigen PET/CT-guided Robotic-assisted Transgluteal Prostatic Biopsy

   38 citations · 2022
2. 2
   Diagnostic performance of real-time robotic arm-assisted 18F-FDG PET/CT-guided percutaneous biopsy in metabolically active abdominal and pelvic lesions

   21 citations · 2018
3. 3
   Positron emission tomography/computed tomography guided percutaneous biopsies of Ga-68 avid lesions using an automated robotic arm

   17 citations · 2019

Key Collaborators

Contact & Links